Evidence map›Paper›PMID 33496263›Full record

ArticleeLife2021

A live attenuated-vaccine model confers cross-protective immunity against different species of the Leptospira genus.

Elsio A Wunder, Haritha Adhikarla, Camila Hamond, Katharine A Owers Bonner, Li Liang, Camila B Rodrigues, Vimla Bisht, Jarlath E Nally, David P Alt, Mitermayer G Reis and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Scoping Review of Antimicrobial Therapy inAnimals : an open access journal from MDPI · 2025
    Review
  5. Article
  6. Leptospirosis.Nature reviews. Disease primers · 2025
    Review
  7. Article
  8. Serovar-specific genomic features ofFrontiers in molecular biosciences · 2025
    Article
  9. Article
  10. Article
  11. Exposure to live saprophyticbioRxiv : the preprint server for biology · 2024
    Article
  12. Epidemiology ofMicroorganisms · 2023
    Article
  13. Vaccines · 2023
    Article
  14. Article
  15. Evaluation ofFrontiers in microbiology · 2023
    Article
  16. Comparison of the PF07598-Encoded Virulence-Modifying Proteins ofTropical medicine and infectious disease · 2022
    Review
  17. Tropical medicine and infectious disease · 2022
    Article
  18. Article
  19. Vaccination WithFrontiers in cellular and infection microbiology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Elsio A WunderDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health, New Haven, United States.ORCID 0000-0002-5239-8511
Haritha AdhikarlaDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health, New Haven, United States.
Camila HamondDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health, New Haven, United States.
Katharine A Owers BonnerDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health, New Haven, United States.ORCID 0000-0002-5323-5079
Li LiangDepartment of Medicine, Division of Infectious Disease; University of California Irvine, Irvine, United States.ORCID 0000-0001-6185-2651
Camila B RodriguesDepartment of Medicine, Division of Infectious Disease; University of California Irvine, Irvine, United States.
Vimla BishtDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health, New Haven, United States.
Jarlath E NallyInfectious Bacterial Diseases Research Unit, National Animal Disease Center, Agricultural Research Service; United States Department of Agriculture, Ames, United States.
David P AltInfectious Bacterial Diseases Research Unit, National Animal Disease Center, Agricultural Research Service; United States Department of Agriculture, Ames, United States.
Mitermayer G ReisGonçalo Moniz Institute, Oswaldo Cruz Foundation; Brazilian Ministry of Health, Salvador, Brazil.
Peter J DiggleCHICAS, Lancaster Medical School; Lancaster University, Lancaster, United Kingdom.
Philip L FelgnerDepartment of Medicine, Division of Infectious Disease; University of California Irvine, Irvine, United States.
Albert KoDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health, New Haven, United States.ORCID 0000-0001-9023-2339
Yale University · USUniversity of California, Irvine · USAgricultural Research Service · USLancaster University · GBMinistério da Saúde · BR

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Naturally-Acquired and Vaccine-Mediated Immunity to LeptospirosisR01AI121207 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG, REIS, MITERMAYER GALVAO DOS · 2016 to 2020
$6.4M
Disease Determinants of Urban LeptospirosisU01AI088752 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG · 2010 to 2014
$3.6M
Natural History of Urban LeptospirosisR01AI052473 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG · 2003 to 2013
$2.8M
Ecoepidemiology of leptospirosis in the urban slums of BrazilR01TW009504 · FIC · YALE UNIVERSITY · PI BEGON, MICHAEL, CHILDS, JAMES EMORY · 2012 to 2016
$2.2M
FIC NIH HHS R01 TW009504NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI052473NIAID NIH HHS R01 AI121207NIAID NIH HHS U01 AI088752NIH HHS R01AI052473NIH HHS R01AI121207NIH HHS R01TW009504NIH HHS U01AI088752
6 · The paper itself

Abstract

Leptospirosis is the leading zoonotic disease in terms of morbidity and mortality worldwide. Effective prevention is urgently needed as the drivers of disease transmission continue to intensify. The key challenge has been developing a widely applicable vaccine that protects against the >300 serovars that can cause leptospirosis. Live attenuated mutants are enticing vaccine candidates and poorly explored in the field. We evaluated a recently characterized motility-deficient mutant lacking the expression of a flagellar protein, FcpA. Although the

Indexed as

AnimalsBacterial VaccinesCross ProtectionFemaleLeptospira interrogansLeptospirosisMaleMesocricetusMiceMice, Inbred C57BLVaccines, AttenuatedBacterial VaccinesVaccines, Attenuatedcross-protective immunityinfectious diseaseleptospiraleptospirosislive attenuated vaccinemicrobiology

Identifiers

PMID33496263
PMCPMC7837694
OpenAlexW3120548852

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.